Catherine Ramsey
Stock Analyst at Baird
(3.92)
# 629
Out of 5,106 analysts
53
Total ratings
53.66%
Success rate
12.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Ramsey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CSTL Castle Biosciences | Maintains: Outperform | $39 → $41 | $40.25 | +1.86% | 9 | Nov 4, 2025 | |
| RVTY Revvity | Maintains: Outperform | $122 → $123 | $97.58 | +26.05% | 6 | Oct 28, 2025 | |
| ILMN Illumina | Maintains: Neutral | $84 → $105 | $136.19 | -22.90% | 6 | Jul 28, 2025 | |
| WAT Waters | Maintains: Outperform | $374 → $352 | $383.21 | -8.14% | 11 | Jul 16, 2025 | |
| TWST Twist Bioscience | Maintains: Outperform | $54 → $44 | $33.84 | +30.02% | 7 | May 6, 2025 | |
| NTRA Natera | Maintains: Outperform | $183 → $188 | $235.40 | -20.14% | 6 | Feb 28, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $695 → $665 | $579.94 | +14.67% | 2 | Nov 1, 2022 | |
| A Agilent Technologies | Maintains: Outperform | $155 → $160 | $138.36 | +15.64% | 5 | Aug 17, 2022 | |
| EXAS Exact Sciences | Maintains: Outperform | $90 → $75 | $101.59 | -26.17% | 1 | Aug 3, 2022 |
Castle Biosciences
Nov 4, 2025
Maintains: Outperform
Price Target: $39 → $41
Current: $40.25
Upside: +1.86%
Revvity
Oct 28, 2025
Maintains: Outperform
Price Target: $122 → $123
Current: $97.58
Upside: +26.05%
Illumina
Jul 28, 2025
Maintains: Neutral
Price Target: $84 → $105
Current: $136.19
Upside: -22.90%
Waters
Jul 16, 2025
Maintains: Outperform
Price Target: $374 → $352
Current: $383.21
Upside: -8.14%
Twist Bioscience
May 6, 2025
Maintains: Outperform
Price Target: $54 → $44
Current: $33.84
Upside: +30.02%
Natera
Feb 28, 2025
Maintains: Outperform
Price Target: $183 → $188
Current: $235.40
Upside: -20.14%
Thermo Fisher Scientific
Nov 1, 2022
Maintains: Outperform
Price Target: $695 → $665
Current: $579.94
Upside: +14.67%
Agilent Technologies
Aug 17, 2022
Maintains: Outperform
Price Target: $155 → $160
Current: $138.36
Upside: +15.64%
Exact Sciences
Aug 3, 2022
Maintains: Outperform
Price Target: $90 → $75
Current: $101.59
Upside: -26.17%